This Week in Psychedelics
Sep 30, 2026
•
5 min read
[5-min read] Study suggests age moderates the relationship between psychedelic use and mental health.
Sep 23, 2026
[5-min read] New esketamine study links dissociation to outcomes in depression.
Sep 16, 2026
[5-min read] FDA holds a public hearing on psychedelic medicine.
Sep 9, 2026
[5-min read] Psilocybin may prevent a severe side effect of chemotherapy.
Sep 2, 2026
[5-min read] THC produces psychedelic effects in Johns Hopkins pilot study.
Aug 26, 2026
[5-min read] Real-world study finds Oregon psilocybin services are safe and meaningful for participants.
Aug 19, 2026
[5-min read] Definium Therapeutics shares results from Phase 3 LSD-for-anxiety trial.
Aug 12, 2026
[5-min read] Althea publishes real-world data from regulated psilocybin services.
Aug 5, 2026
[5-min read] Veterans with severe PTSD respond to psilocybin therapy in pilot trial.
Jul 29, 2026
[5-min read] Center for Psychedelic Policy challenges Oregon's proposed psilocybin license fees.
Jul 22, 2026
[5-min read] Lilly acquires AtaiBeckley for up to $3.8 billion.
Jul 15, 2026
[5-min read] HHS & VA announce coordinated effort to advance psychedelic medicine.
Jul 8, 2026
[5-min read] Psychedelics can stir people's attitudes toward political violence.
Jul 1, 2026
[5-min read] The entropic brain hypothesis holds up as a model for conscious states.
Jun 24, 2026
[5-min read] Definium shares topline Phase 3 results for LSD in depression.
Jun 17, 2026
[5-min read] Personality type may predict the intensity of acute psychedelic effects.
Jun 10, 2026
[5-min read] 5-MeO-DMT delivers 100% remission in small postpartum depression trial.
Jun 3, 2026
[5-min read] Study investigates the link between psychedelics and mania.
May 27, 2026
6 min read
[5-min read] New study suggests psilocybin can significantly reduce neuropathic pain.
May 20, 2026
[5-min read] Two new studies weigh psychedelics as interventions for suicidality.
May 13, 2026
[5-min read] New study captures human brain changes after first psilocybin trip.
May 6, 2026
[5-min read] New study compares 2C-B to psilocybin and MDMA in healthy volunteers.
Apr 29, 2026
[5-min read] FDA awards priority vouchers to Compass, Otsuka, and Usona.
Apr 22, 2026
[5-min read] Trump signs executive order to accelerate psychedelic research and access.
Apr 15, 2026
[5-min read] New study examines MDMA's effects on male reproductive biology.
